Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Paclitaxel Cationic Liposome in Advanced Hepatocellular Carcinoma: NCT07282509 Clinical Landscape Report 2026
16 October 2026
NCT07282509 clinical landscape for Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Rexaceract in Parkinson Disease: NCT07280299 Clinical Landscape Report 2026
16 October 2026
NCT07280299 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lenvatinib mesylate in Hepatocellular Carcinoma: NCT07282184 Clinical Landscape Report 2026
16 October 2026
NCT07282184 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MP-0712 in Large cell neuroendocrine carcinoma of lung: NCT07278479 Clinical Landscape Report 2026
16 October 2026
NCT07278479 clinical landscape for Large cell neuroendocrine carcinoma of lung: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Atezolizumab in Hepatocellular Carcinoma: NCT07285850 Clinical Landscape Report 2026
16 October 2026
NCT07285850 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
RBR-042 in Pulmonary Disease, Chronic Obstructive: NCT07285122 Clinical Landscape Report 2026
16 October 2026
NCT07285122 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Levoleucovorin in Recurrent Colon Cancer: NCT07283939 Clinical Landscape Report 2026
16 October 2026
NCT07283939 clinical landscape for Recurrent Colon Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Atezolizumab in Unresectable Hepatocellular Carcinoma: NCT07281664 Clinical Landscape Report 2026
16 October 2026
NCT07281664 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Buntanetap in Parkinson Disease: NCT07284784 Clinical Landscape Report 2026
16 October 2026
NCT07284784 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BBT002 in Pulmonary Disease, Chronic Obstructive: NCT07288554 Clinical Landscape Report 2026
16 October 2026
NCT07288554 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Terazosin Hydrochloride in Parkinson Disease: NCT07288450 Clinical Landscape Report 2026
16 October 2026
NCT07288450 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Recombinant humanized anti-ST2 monoclonal antibody (Mabwell) in Pulmonary Disease, Chronic Obstructive: NCT07292714 Clinical Landscape Report 2026
16 October 2026
NCT07292714 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…